A two-stage differential hydrogen deuterium exchange method for the rapid characterization of protein/ligand interactions

Journal of Biomolecular Techniques

Volumn 18, Issue 4, 2007, Pages 194-204

  Chalmers, Michael J ^a   Busby, Scott A ^a   Pascal, Bruce D ^a   Southern, Mark R ^a   Griffin, Patrick R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

HDX; Mass spectrometry; Nuclear receptor; PPAR

Indexed keywords

DEUTERIUM; HYDROGEN; LIGAND; PROTEIN;

ARTICLE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; PROTEIN BINDING;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEUTERIUM; HYDROGEN; LIGANDS; MASS SPECTROMETRY; PROTEIN BINDING; PROTEINS;

EID: 36049032359     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Robinson-Rechavi M, Escriva Garcia H, Laudet V. The nuclear receptor superfamily. J Cell Sci 2003;116(Pt 4):585-586.
2. Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 2004;3(11):950-964.
3. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: The second decade. Cell 1995;83(6):835-839.
4. Kiec-Wilk B, Dembinska-Kiec A, Olszanecka A, Bodzioch M, Kawecka-Jaszcz K. The selected pathophysiological aspects of PPARs activation. J Physiol Pharmacol 2005;56(2):149-162.
5. Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999;354(9173):141-148.
6. Schoonjans K, Auwerx J. Thiazolidinediones: An update. Lancet 2000;355(9208):1008-1010.
7. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347(6294):645-650.
8. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 1998;395(6698):137-143.
9. Uppenberg J, Svensson C, Jaki M, Bertilsson G, Jendeberg L, Berkenstam A. Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma. J Biol Chem 1998;273(47): 108-31.
10. Jordan VC. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions. J Med Chem 2003;46(6):883-908.
11. Goldfrank D, Haytoglu T, Frishman WH, Mohammad Z. Raloxifene, a new selective estrogen receptor modulator. J Clin Pharmacol 1999;39(8):767-774.
12. Berger JP, Petro AE, Macnaul KL, Kelly LJ, Zhang BB, Richards K, et al. Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator. Mol Endocrinol 2003;17(4):662-676.
13. Reginato MJ, Bailey ST, Krakow SL, Minami C, Ishii S, Tanaka H, et al. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties. J Biol Chem 1998;273(49):679-32.
14. Rocchi S, Picard F, Vamecq J, Gelman L, Potier N, Zeyer D, et al. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell 2001;8(4):737-747.
15. Acton JJ, 3rd, Black RM, Jones AB, Moller DE, Colwell L, Doebber TW, et al. Benzoyl 2-methyl indoles as selective PPARgamma modulators. Bioorg Med Chem Lett 2005;15(2):357-362.
16. Ostberg T, Svensson S, Selen G, Uppenberg J, Thor M, Sundbom M, et al. A new class of peroxisome proliferator-activated receptor agonists with a novel binding epitope shows antidiabetic effects. J Biol Chem 2004;279(39):41124-41130.
17. Bai YW, Milne JS, Mayne L, Englander SW. Primary structure effects on peptide group hydrogen-exchange. Proteins Struct Funct Gen 1993;17(1):75-86.
18. Busenlehner LS, Armstrong RN. Insights into enzyme structure and dynamics elucidated by amide H/D exchange mass spectrometry. Arch Biochem Biophys 2005;433(1):34-46.
19. Chamberlain AK, Marqusee S. Touring the landscapes: Partially folded proteins examined by hydrogen exchange. Structure 1997;5(7):859-863.
20. Engen JR, Smith DL. Investigating protein structure and dynamics by hydrogen exchange MS. Anal Chem 2001;73(9):256A-265A.
21. Englander SW, Kallenbach NR. Hydrogen-exchange and structural dynamics of proteins and nucleic-acids. Q Rev Biophys 1983;16(4):521-655.
22. Englander SW, Mayne L, Bai Y, Sosnick TR. Hydrogen exchange: The modern legacy of Linderstrom-Lang. Protein Sci 1997;6(5):1101-1109.
23. Garcia RA, Pantazatos D, Villarreal FJ. Hydrogen/deuterium exchange mass spectrometry for investigating protein-ligand interactions. Assay Drug Dev Technol 2004;2(1):81-91.
24. Griffin PR, Hamuro Y, Coales SJ, Southern MR. Ligand induced stabilization of nuclear receptors: Use of hydrogen deuterium exchange mass spectrometry to guide design of specific nhr modulators. Abst Pap Amer Chem Soc 2004;228:U532-U532.
25. Hamuro Y, Wong L, Shaffer J, Kim JS, Stranz DD, Jennings PA, et al. Phosphorylation driven motions in the COOH-terminal Src kinase, Csk, revealed through enhanced hydrogendeuterium exchange and mass spectrometry (DXMS). J Mol Biol 2002;323(5):871-881.
26. Hamuro Y, Zawadzki KM, Kim JS, Stranz DD, Taylor SS, Woods VL. Dynamics of cAPK type II beta activation revealed by enhanced amide H/H-2 exchange mass spectrometry (DXMS). J Mol Biol 2003;327(5):1065-1076.
27. Lisal J, Lam TT, Kainov DE, Emmett MR, Marshall AG, Tuma R. Functional visualization of viral molecular motor by hydrogen-deuterium exchange reveals transient states. Nat Struct Biol 2005;12(5):460-466.
28. Nazabal A, Maddelein ML, Bonneu M, Saupe SJ, Schmitter JM. Probing the structure of the infectious amyloid form of the prionforming domain of HET-s using high resolution hydrogen/deuterium exchange monitored by mass spectrometry. J Biol Chem 2005;280(14):220-13.
29. Sivaraman T, Arrington CB, Robertson AD. Kinetics of unfolding and folding from amide hydrogen exchange in native ubiquitin. Nat Struct Biol 2001;8(4):331-333.
30. Winters MS, Spellman DS, Lambris JD. Solvent accessibility of native and hydrolyzed human complement protein 3 analyzed by hydrogen/deuterium exchange and mass spectrometry. J Immunol 2005;174(6):3469-3474.
31. Yan XG, Broderick D, Leid ME, Schimerlik MI, Deinzer ML. Dynamics and ligand-induced solvent accessibility changes in human retinoid X receptor homodimer determined by hydrogen deuterium exchange and mass spectrometry. Biochemistry 2004;43(4):909-917.
32. Yan XG, Watson J, Ho PS, Deinzer ML. Mass spectrometric approaches using electrospray ionization charge states and hydrogen-deuterium exchange for determining protein structures and their conformational changes. Mol Cell Proteomics 2004;3(1):10-23.
33. Zhang Z, Smith DL. Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation. Protein Sci 1993;2(4):522-531.
34. Egea J, Espinet C, Soler RM, Peiro S, Rocamora N, Comella JX. Nerve growth factor activation of the extracellular signalregulated kinase pathway is modulated by Ca2+ and calmodulin. Mol Cell Biol 2000;20(6):1931-1946.
35. Hamuro Y, Coales SJ, Southern MR, Nemeth-Cawley JF, Stranz DD, Griffin PR. Rapid analysis of protein structure and dynamics by hydrogen/deuterium exchange mass spectrometry. J Biomol Tech 2003;14(3):171-182.
36. Chalmers MJ, Busby SA, Pascal BD, He Y, Hendrickson CL, Marshall AG, et al. Probing protein ligand interactions by automated hydrogen/deuterium exchange mass spectrometry. Anal Chem 2006;78(4):1005-1014.
37. Hamuro Y, Coales SJ, Morrow JA, Molnar KS, Tuske SJ, Southern MR, et al. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators. Protein Sci 2006;15(8):1883-1892.
38. Wu Y, Engen JR, Hobbins WB. Ultra performance liquid chromatography (UPLC) further improves hydrogen/deuterium exchange mass spectrometry. J Am Soc Mass Spectrometry 2006;17(2):163-167.
39. Busby SA, Chalmers MJ, Griffin PR. Improving digestion efficiency under H/D exchange conditions with activated pepsinogen coupled columns. Int J Mass Spectrometry 2007;259(1-3):130-139.
40. Pascal BD, Chalmers MJ, Busby SA, Mader CC, Southern MR, Tsinoremas NF, et al. The Deuterator: Software for the determination of backbone amide deuterium levels from H/D exchange MS data. BMC Bioinformatics 2007;8(1):156.
41. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995;83(5):803-812.
42. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995;83(5):813-819.
43. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998;93(2):229-240.
44. Schild RL, Schaiff WT, Carlson MG, Cronbach EJ, Nelson DM, Sadovsky Y. The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids. J Clin Endocrinol Metabolism 2002;87(3):1105-1110.